During the past decade, National Health Insurance Corporation Ilsan Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Health Insurance Corporation Ilsan Hospital" #1 sponsor was "Seung-Jung Park" with 16 trials, followed by "Allergan" with 4 trials sponsored, "Seoul National University Hospital" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Asan Medical Center" with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Health Insurance Corporation Ilsan Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 16 trials as a collaborator, "Medtronic" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Biotronik SE & Co. KG" with 2 trials as a collaborator and "Korean Cancer Study Group" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "National Health Insurance Corporation Ilsan Hospital" are "Coronary Artery Disease" (15 trials), "Cerebral Palsy" (4 trials), "Muscle Spasticity" (4 trials), "Pediatrics" (4 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "National Health Insurance Corporation Ilsan Hospital" in a lesser frequency.

Most popular intervention types in "National Health Insurance Corporation Ilsan Hospital" are "Drug" (33 trials), "Device" (15 trials), "Procedure" (5 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Aspirin" (2 trials), "Aspirin,Clopidogrel" (2 trials), "Botulinum Toxin Type A" (2 trials) and "Cypher" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Health Insurance Corporation Ilsan Hospital" are 59 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "National Health Insurance Corporation Ilsan Hospital". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in National Health Insurance Corporation Ilsan Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in National Health Insurance Corporation Ilsan Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 11 trials that are defined as “Not Applicable".